PostmenopausalNCT07131215
Smart Technology-Based Intervention and Monitoring of Physical and Mental Health in Early Postmenopausal Women
A study testing Home-based multimodal exercise, Supervised multimodal exercise program and Education in people with Postmenopausal and Postmenopausal Disorder, run by YI-JU TSAI at 1 site in Taiwan.
Trial summary
The aim of this study is to compare the short-term and long-term effects of an 8-week home-based multimodal exercise program, delivered through a smartphone app, on quality of life, muscle function, and physical performance in early postmenopausal women. Read more about this study
- Who is it for?
- Ages 40 to 65 years, women only
- Conditions the study is for
- Postmenopausal, Postmenopausal Disorder, Menopause
- What is being tested?
- Home-based multimodal exercise, Supervised multimodal exercise program and Education
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 90 participants
- Where
- 1 siteTaiwan
- Study dates
- 15 Aug 2025to 31 Jul 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 65 years
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 45 to 65-year-old postmenopausal women
- At least 12 months of amenorrhea
- Within 6 years after menopause
Who cannot join
- Exercised more than twice a week for at least 30 minutes per session
- Received hormone therapy in the past three months
- Neurological disease (e.g., spinal cord injury, multiple sclerosis, stroke) or cardiovascular diseases
- History of pelvic or prolapse surgery (excluding cesarean section)
- History of malignancy affecting the bladder, urethra, uterus, ovary, cervix, or rectum
- Using medications that could affect heart rate or mood
- Body mass index (BMI) > 35 kg/m²
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Taiwan1 site, 1 recruiting
- Recruiting
National Cheng Kung University
Tainan, 701
Yi-Ju Tsai, Ph.D., +886 6 2353535 ext. 5021, yijutsai@mail.ncku.edu.tw
Shih-Ting Lee, lish610216@gmail.com
About this study
The aim of this study is to compare the short-term and long-term effects of an 8-week home-based multimodal exercise program, delivered through a smartphone app, on quality of life, muscle function, and physical performance in early postmenopausal women.
Read the detailed description
The goal of this study is to investigate whether a comprehensive exercise program in early postmenopause can improve quality of life, physical function, and long-term health.
The main question it aims to answer is:
Does adding exercise intervention in early postmenopause will improve their quality of life and long-term health?
- Conditions
- Postmenopausal, Postmenopausal Disorder, Menopause
- Being tested
- Home-based multimodal exercise, Supervised multimodal exercise program, Education
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Home-based multimodal exerciseOther
Mobile Applications
Supervised multimodal exercise programOther
In laboratory
EducationOther
Menopause education
| Study group | Role | What they receive |
|---|---|---|
| APP exercise group | Experimental | 8-week home-based multimodal exercise program via customized mobile APP Receives: Other: Home-based multimodal exercise; Other: Education |
| Supervised exercise group | Experimental | 8-week supervised exercise program in the laboratory Receives: Other: Supervised multimodal exercise program; Other: Education |
| Education control group | Other | 30-minute educational session Receives: Other: Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Muscle function measures for lumbopelvic muscle: Abdominal and back muscles
Ultrasonography images of muscle thickness of abdominal and back muscles during rest and during active straight leg raise. Each condition will be tested three times. Muscle thickness at rest and during contraction will be measured using ImageJ, with results expressed in millimeters (mm)
Measured: Changes from baseline to 8 weeks when participants finish the intervention.
Muscle function measures for lumbopelvic muscle
Ultrasonography images of bladder displacement for pelvic floor muscles during rest, maximum contraction, and during active straight leg raise. Each condition will be tested three times. Bladder height differences between contraction and relaxation of the pelvic floor muscles will be measured using ImageJ, with results expressed in millimeters (mm).
Measured: Changes from baseline to 8 weeks when participants finish the intervention.
Functional performance of Supine isometric chest lift test
The Supine Isometric Chest Lift Test will be used to assess the endurance of the abdominal muscles. Participants lie in a supine position and are instructed to lift the head and shoulders off the floor, maintaining the isometric position as long as possible. The holding time is recorded in seconds
Measured: Changes from baseline to 8 weeks when participants finish the intervention.
Functional performance of Double Straight-Leg Raise Test
The Double Straight-Leg Raise Test will be used to assess the endurance of the trunk flexor muscles. Participants lie supine and are instructed to raise both legs to approximately 45 degrees and maintain this position as long as possible. The holding time is recorded in seconds
Measured: Changes from baseline to 8 weeks when participants finish the intervention.
Functional performance of sorensen test
The Sorensen test will be used to assess the endurance of the back extensor muscles. Participants lie prone with the upper body extended beyond the edge of a table and are instructed to maintain a horizontal trunk position as long as possible. The total holding time is recorded in seconds
Measured: Changes from baseline to 8 weeks when participants finish the intervention.
Functional performance of Active straight-leg raise fatigue task
Participants lifted the heel of the test leg to 20 cm for as long as possible. Participants were required to maintain pressure in the cuff beneath their back as close to 40 mm Hg as possible. Visual feedback of cuff pressure was provided throughout the task, but no instruction was given on how to affect cuff pressure. Task failure was defi ned as an inability to maintain heel height 10 cm or more off the plinth and/or a change in cuff pressure of 20 mm Hg or more.
Measured: Changes from baseline to 8 weeks when participants finish the intervention.
Endurance of the pelvic stabilizing muscles
The manometry will provide measurements of pelvic floor muscle (PFM) function, including peak contraction pressure, average contraction pressure, and endurance capacity.
Measured: Changes from baseline to 8 weeks when participants finish the intervention.
Functional performance of timed up and go test
Test instructions were given in Norwegian. Translated into English, the instructions were as follows: 'After "ready, set, go" stand up, walk as fast as you can until you cross the white line, turn around, and walk back to the chair and sit down again'. The white line was positioned 3m from the patient's starting position.
Measured: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
Functional performance of 6-Meter Walk Test
Subjects commenced the test in standing with their toes up against the tape marker. Test instructions translated into English were as follows: 'After "ready, set, go", walk as fast as you can up to the last white line without stopping or speaking along the way'. Performances were timed (to the nearest 100th of a second) between the 2m and 8m markers and later converted into speed in metres per second.
Measured: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
Functional performance of Four-Square Step Test
The Four-Square Step Test (FSST) will be used to assess dynamic balance and mobility. Participants are required to step rapidly in a specific sequence across four squares. The total time to complete the sequence is recorded in seconds.
Measured: Changes from baseline to 8 weeks when participants finish the intervention.
Functional performance of Single-Leg Stance Test
The Single-Leg Stance Test (SLST) will be used to assess static balance. Participants stand unassisted on one leg for as long as possible, with the test terminated when balance is lost or the non-supporting foot touches the ground. The holding time is recorded in seconds
Measured: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
Body composition
The InBody 770 bioelectrical impedance analysis (BIA) system will provide measurements of skeletal muscle mass (kg), lean body mass (kg), and total body water (L)
Measured: Changes from baseline to 8 weeks when participants finish the intervention.
Body composition and bone mineral density
The dual-energy X-ray absorptiometry (DXA) system will provide measurements of bone mineral density (BMD) at the lumbar spine and hip regions (g/cm²)
Measured: Changes from baseline to 8 weeks when participants finish the intervention.
Effectiveness of the app:System Usability Scale (SUS)
The System Usability Scale (SUS) will be used to evaluate the usability and user satisfaction of the system. The total score is converted to a 0-100 scale, where 0 represents the lowest usability and 100 represents the highest usability. Higher scores indicate better usability
Measured: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
Effectiveness of the app:Patient Satisfaction and Usability with Apps Questionnaire
The Patient Satisfaction and Usability with Apps Questionnaire (pSUAPP) will be used to evaluate participants' satisfaction and perceived usability of the mobile health application. The total score ranges from 28 to 140 . Higher total scores indicate better user experience and app functionality
Measured: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
Self-perceived Change:Global Rating of Change Scale (GROC)
The Global Rating of Change Scale (GROC) rates perceived "overall change" on a 15-point Likert scale, with 7 (labeled "worse") on the left, +7 (labeled "better") on the right, and 0 in the middle (labeled "no change") compared to the baseline.
Measured: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
Quality of life and menopause related questionnaire:Brief Pain Inventory (BPI)
The Brief Pain Inventory (BPI) will be used to assess overall pain intensity and pain-related interference with daily activities. Each item is scored on a 0-10 scale.Higher scores represent worse outcomes.
Measured: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
Menopause related questionnaire:Menopause-Specific Quality of Life Questionnaire (MENQOL)
The Menopause-Specific Quality of Life Questionnaire (MENQOL) will provide domain-specific and overall scores assessing the impact of menopause on quality of life. The total score ranges from 0 to 174, with higher scores indicating worse symptoms and a greater negative impact on quality of life.
Measured: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
Quality of life and menopause related questionnaire:International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)
The International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) will provide a total score (0-21) to evaluate the severity of urinary incontinence and its impact on quality of life, with higher scores indicating greater symptom severity.
Measured: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
Quality of life and menopause related questionnaire:Incontinence Quality of Life (I-QoL)
The Incontinence Quality of Life (I-QoL) questionnaire will assess quality of life related to urinary incontinence. Scores are transformed to a 0-100 scale. Higher scores indicate better incontinence-related quality of life
Measured: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
Quality of life and menopause related questionnaire:International Physical Activity Questionnaire-Short Form (IPAQ-SF)
The International Physical Activity Questionnaire-Short Form (IPAQ-SF) will be used to assess physical activity levels over the past 7 days
Measured: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Aug 2025
- Study start15 Aug 2025
- Primary completion30 Jul 2028 (estimated)
- Study completion31 Jul 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PostmenopausalStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 90 participants (estimated)
Sponsor and investigators
- Lead sponsor
- YI-JU TSAI
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, YI-JU TSAI, National Cheng Kung University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07131215
- Sponsor's protocol ID
- NCKU_Postmenopausal
- Status last verified
- Apr 2026
- First submitted
- 20 Jul 2025
- Last updated
- 14 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Smart Technology-Based Intervention and Monitoring of Physical and Mental Health in Early Postmenopausal Women
- ClinicalTrials.gov ID
- NCT07131215
- Acronym / sponsor ID
- NCKU_Postmenopausal
- Conditions
- Postmenopausal, Postmenopausal Disorder, Menopause
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 90 participants (estimated)
- Lead sponsor
- YI-JU TSAIUniversity, hospital or other
- Study start
- 15 Aug 2025 (actual)
- Primary completion
- 30 Jul 2028 (estimated)
- Study completion
- 31 Jul 2028 (estimated)
- First posted
- 20 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to compare the short-term and long-term effects of an 8-week home-based multimodal exercise program, delivered through a smartphone app, on quality of life, muscle function, and physical performance in early postmenopausal women.
Detailed description
The goal of this study is to investigate whether a comprehensive exercise program in early postmenopause can improve quality of life, physical function, and long-term health.
The main question it aims to answer is:
Does adding exercise intervention in early postmenopause will improve their quality of life and long-term health?
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| APP exercise group | Experimental | Other: Home-based multimodal exercise, Other: Education8-week home-based multimodal exercise program via customized mobile APP |
| Supervised exercise group | Experimental | Other: Supervised multimodal exercise program, Other: Education8-week supervised exercise program in the laboratory |
| Education control group | Other | Other: Education30-minute educational session |
Who may qualify
- Ages
- 40 to 65 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- 45 to 65-year-old postmenopausal women
- At least 12 months of amenorrhea
- Within 6 years after menopause
Key exclusion criteria (7 listed)
- Exercised more than twice a week for at least 30 minutes per session
- Received hormone therapy in the past three months
- Neurological disease (e.g., spinal cord injury, multiple sclerosis, stroke) or cardiovascular diseases
- History of pelvic or prolapse surgery (excluding cesarean section)
- History of malignancy affecting the bladder, urethra, uterus, ovary, cervix, or rectum
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Home-based multimodal exerciseMobile Applications | Other | APP exercise group |
| Supervised multimodal exercise programIn laboratory | Other | Supervised exercise group |
| EducationMenopause education | Other | APP exercise group, Education control group, Supervised exercise group |
Primary outcome
Muscle function measures for lumbopelvic muscle: Abdominal and back muscles
Time frame: Changes from baseline to 8 weeks when participants finish the intervention.
Ultrasonography images of muscle thickness of abdominal and back muscles during rest and during active straight leg raise. Each condition will be tested three times. Muscle thickness at rest and during contraction will be measured using ImageJ, with results expressed in millimeters (mm)
Muscle function measures for lumbopelvic muscle
Time frame: Changes from baseline to 8 weeks when participants finish the intervention.
Ultrasonography images of bladder displacement for pelvic floor muscles during rest, maximum contraction, and during active straight leg raise. Each condition will be tested three times. Bladder height differences between contraction and relaxation of the pelvic floor muscles will be measured using ImageJ, with results expressed in millimeters (mm).
Functional performance of Supine isometric chest lift test
Time frame: Changes from baseline to 8 weeks when participants finish the intervention.
The Supine Isometric Chest Lift Test will be used to assess the endurance of the abdominal muscles. Participants lie in a supine position and are instructed to lift the head and shoulders off the floor, maintaining the isometric position as long as possible. The holding time is recorded in seconds
Functional performance of Double Straight-Leg Raise Test
Time frame: Changes from baseline to 8 weeks when participants finish the intervention.
The Double Straight-Leg Raise Test will be used to assess the endurance of the trunk flexor muscles. Participants lie supine and are instructed to raise both legs to approximately 45 degrees and maintain this position as long as possible. The holding time is recorded in seconds
Functional performance of sorensen test
Time frame: Changes from baseline to 8 weeks when participants finish the intervention.
The Sorensen test will be used to assess the endurance of the back extensor muscles. Participants lie prone with the upper body extended beyond the edge of a table and are instructed to maintain a horizontal trunk position as long as possible. The total holding time is recorded in seconds
Functional performance of Active straight-leg raise fatigue task
Time frame: Changes from baseline to 8 weeks when participants finish the intervention.
Participants lifted the heel of the test leg to 20 cm for as long as possible. Participants were required to maintain pressure in the cuff beneath their back as close to 40 mm Hg as possible. Visual feedback of cuff pressure was provided throughout the task, but no instruction was given on how to affect cuff pressure. Task failure was defi ned as an inability to maintain heel height 10 cm or more off the plinth and/or a change in cuff pressure of 20 mm Hg or more.
Endurance of the pelvic stabilizing muscles
Time frame: Changes from baseline to 8 weeks when participants finish the intervention.
The manometry will provide measurements of pelvic floor muscle (PFM) function, including peak contraction pressure, average contraction pressure, and endurance capacity.
Functional performance of timed up and go test
Time frame: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
Test instructions were given in Norwegian. Translated into English, the instructions were as follows: 'After "ready, set, go" stand up, walk as fast as you can until you cross the white line, turn around, and walk back to the chair and sit down again'. The white line was positioned 3m from the patient's starting position.
Functional performance of 6-Meter Walk Test
Time frame: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
Subjects commenced the test in standing with their toes up against the tape marker. Test instructions translated into English were as follows: 'After "ready, set, go", walk as fast as you can up to the last white line without stopping or speaking along the way'. Performances were timed (to the nearest 100th of a second) between the 2m and 8m markers and later converted into speed in metres per second.
Functional performance of Four-Square Step Test
Time frame: Changes from baseline to 8 weeks when participants finish the intervention.
The Four-Square Step Test (FSST) will be used to assess dynamic balance and mobility. Participants are required to step rapidly in a specific sequence across four squares. The total time to complete the sequence is recorded in seconds.
Functional performance of Single-Leg Stance Test
Time frame: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
The Single-Leg Stance Test (SLST) will be used to assess static balance. Participants stand unassisted on one leg for as long as possible, with the test terminated when balance is lost or the non-supporting foot touches the ground. The holding time is recorded in seconds
Body composition
Time frame: Changes from baseline to 8 weeks when participants finish the intervention.
The InBody 770 bioelectrical impedance analysis (BIA) system will provide measurements of skeletal muscle mass (kg), lean body mass (kg), and total body water (L)
Body composition and bone mineral density
Time frame: Changes from baseline to 8 weeks when participants finish the intervention.
The dual-energy X-ray absorptiometry (DXA) system will provide measurements of bone mineral density (BMD) at the lumbar spine and hip regions (g/cm²)
Effectiveness of the app:System Usability Scale (SUS)
Time frame: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
The System Usability Scale (SUS) will be used to evaluate the usability and user satisfaction of the system. The total score is converted to a 0-100 scale, where 0 represents the lowest usability and 100 represents the highest usability. Higher scores indicate better usability
Effectiveness of the app:Patient Satisfaction and Usability with Apps Questionnaire
Time frame: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
The Patient Satisfaction and Usability with Apps Questionnaire (pSUAPP) will be used to evaluate participants' satisfaction and perceived usability of the mobile health application. The total score ranges from 28 to 140 . Higher total scores indicate better user experience and app functionality
Self-perceived Change:Global Rating of Change Scale (GROC)
Time frame: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
The Global Rating of Change Scale (GROC) rates perceived "overall change" on a 15-point Likert scale, with 7 (labeled "worse") on the left, +7 (labeled "better") on the right, and 0 in the middle (labeled "no change") compared to the baseline.
Quality of life and menopause related questionnaire:Brief Pain Inventory (BPI)
Time frame: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
The Brief Pain Inventory (BPI) will be used to assess overall pain intensity and pain-related interference with daily activities. Each item is scored on a 0-10 scale.Higher scores represent worse outcomes.
Menopause related questionnaire:Menopause-Specific Quality of Life Questionnaire (MENQOL)
Time frame: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
The Menopause-Specific Quality of Life Questionnaire (MENQOL) will provide domain-specific and overall scores assessing the impact of menopause on quality of life. The total score ranges from 0 to 174, with higher scores indicating worse symptoms and a greater negative impact on quality of life.
Quality of life and menopause related questionnaire:International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)
Time frame: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
The International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) will provide a total score (0-21) to evaluate the severity of urinary incontinence and its impact on quality of life, with higher scores indicating greater symptom severity.
Quality of life and menopause related questionnaire:Incontinence Quality of Life (I-QoL)
Time frame: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
The Incontinence Quality of Life (I-QoL) questionnaire will assess quality of life related to urinary incontinence. Scores are transformed to a 0-100 scale. Higher scores indicate better incontinence-related quality of life
Quality of life and menopause related questionnaire:International Physical Activity Questionnaire-Short Form (IPAQ-SF)
Time frame: Changes from baseline to 8 weeks when participants finish the intervention, and follow-up assessments at 3 and 6 months post-intervention.
The International Physical Activity Questionnaire-Short Form (IPAQ-SF) will be used to assess physical activity levels over the past 7 days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Apr 2026.
Related trials for Postmenopausal
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Active, not recruiting
AI-Supported Mobile High-Impact and Strengthening Exercise Program in Postmenopausal Women With Low Bone Density
Osteopenia
Not yet recruiting
The Role of Diet Quality in Sleep Among Women in Postmenopause
Post Menopausal Women
Not yet recruitingObservational study
Spousal Support and Sexual Quality of Life in Postmenopausal Women
Postmenopausal, Support
Not yet recruitingObservational study
Serum Estradiol and Endometrial Thickness After Bariatric Surgery in Postmenopausal Women With Obesity
Obesity, Morbid, Postmenopause
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Home-based multimodal exercise, Supervised multimodal exercise program and Education in people with Postmenopausal and Postmenopausal Disorder, run by YI-JU TSAI at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Yi-Ju Tsai PhD (+886-6-2353535 Ext. 5021, yijutsai@mail.ncku.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Muscle function measures for lumbopelvic muscle: Abdominal and back muscles (time frame: Changes from baseline to 8 weeks when participants finish the intervention.). The study lists 21 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2026.